Head-to-Head Efficacy: STEP (Wegovy) vs SUSTAIN (Ozempic) Trial Data Explained Percent weight-loss, A1C changes, quality-of-life scores The pivotal STEP trials for Wegovy revealed striking weight-loss outcomes, with participants achieving an average body weight reduction of about 15% over 68 weeks
As we know, fatalities in such cases is more than heart attacks
Several service providers reported establishing formal memoranda of understanding (MOUs) with domestic violence shelters to ensure not only placement of their clients but also placement in a facility with staff trained on human trafficking and sensitive to the needs of victims
Heart Failure: In 2013, the SAVOR-TIMI trial reported a significantly increased risk of hospitalization for heart failure (HF) in patients taking saxagliptin
In an interview with Pharmaceutical Commerce, Colin Banas, MD, DrFirst chief medical officer, discussed the challenges many Americans face in accessing GLP-1 drugs due to their high cost
